Vemurafenib

Cancer Network Podcasts

13 years ago

Advances in Metastatic Melanoma Care

melanoma

braf

inhibitor

vemurafenib

ipilimumab

+5

+4

+3

+3

+2

+2

+2

+1

16:47

melanoma

braf

inhibitor

vemurafenib

ipilimumab

+5

+4

+3

+3

+2

+2

+2

+1

Journal of Clinical Oncology P

13 years ago

Novel Insights From a Phase II MEK Inhibitor Trial in BRAF Mutant Melanoma

melanoma

mek

braf

vemurafenib

dabrafenib

+5

+4

+3

+3

+2

+2

+1

+1

melanoma

mek

braf

vemurafenib

dabrafenib

+5

+4

+3

+3

+2

+2

+1

+1

FirstWord Pharmaceutical News

10 years ago

FirstWord Pharmaceutical News for Thursday, May 12, 2011

johnson & johnson

takeda

nycomed

vemurafenib

teva

+5

+5

+4

+4

+3

+3

+2

+2

10:08

johnson & johnson

takeda

nycomed

vemurafenib

teva

+5

+5

+4

+4

+3

+3

+2

+2